Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nestor F Mercado

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Heart (British Cardiac Society)|September 19, 2006
The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary RevascularisationMattie J Lenzen, Wilma J M Scholte op Reimer, Susanne S Pedersen, et al.
Circulation|February 6, 2004
Clinical and angiographic predictors of restenosis after stent deployment in diabetic patientsNick E J West, Peter N Ruygrok, Clemens M C Disco, et al.
The American Journal of Cardiology|February 8, 2005
Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy)Pedro A Lemos, Patrick W Serruys, Pim de Feyter, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Heart (British Cardiac Society)|September 19, 2006
The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary RevascularisationMattie J Lenzen, Wilma J M Scholte op Reimer, Susanne S Pedersen, et al.
Circulation|February 6, 2004
Clinical and angiographic predictors of restenosis after stent deployment in diabetic patientsNick E J West, Peter N Ruygrok, Clemens M C Disco, et al.
The American Journal of Cardiology|February 8, 2005
Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy)Pedro A Lemos, Patrick W Serruys, Pim de Feyter, et al.
Pageof 1